Fungal infections are becoming common among critically ill patients, as our patient population is increasingly complex and more frequently immunosuppressed. Traditional curricula often focus on antibacterial agents rather than antifungals, leaving antifungal agents shrouded in a sense of mystery. Antifungals actually aren't that tricky though, as there is a very limited number of them.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- PulmCrit – I’m so confused about bamlanivimab - November 30, 2020
- PulmCrit – Oscar awards for the best COVID prognostic models - November 28, 2020
- PulmCrit – Heparin resistance in COVID & implications for DVT prophylaxis - November 24, 2020